---
schema_version: "secwatch.filing_event.v1"
accession: "0001808220-23-000002"
form_type: "8-K"
ticker: "GOCO"
cik: "0001808220"
company_name: "GoHealth, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T18:07:09.114723+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# GoHealth appoints Karolina Hilu as Class III director effective Jan 5, 2023

## Summary
- Ms. Hilu is an independent director and advisor to health tech companies, former CEO of Emsana Health.
- Annual retainer of $150,000 plus $150,000 in RSUs vesting quarterly over four years, pro-rated for partial service.
- Designated by NVX Holdings, Inc. under the Stockholders Agreement; term expires at 2023 annual meeting.
- No committee assignments yet; standard indemnification agreement executed.

## SEC filing metadata
- accession: 0001808220-23-000002
- form_type: 8-K
- ticker: GOCO
- cik: 0001808220
- company_name: GoHealth, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000002/0001808220-23-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000002/goco-20230105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808220-23-000002
- JSON: https://secwatch.observer/filing/0001808220-23-000002.json
- Plain text: https://secwatch.observer/filing/0001808220-23-000002.txt

## Key facts
- Executive change
  Karolina Hilu was appointed as Class III Director at GoHealth, Inc..
  - Action: appointed
  - Role: Class III Director
  source text: On January 5, 2023, the Board of Directors (the “Board”) of the Company appointed Karolina Hilu as a Class III director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000002/0001808220-23-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.